Skip to main navigation Skip to search Skip to main content

Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.

Translated title of the contribution: Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.
  • L.F. van Gaal
  • , A.J. Scheen
  • , H.P.F. Koppeschaar
  • , Study Group RIO-Europe
  • , C. Hanotin
  • , O. Ziegler

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contributionLong-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.
Original languageUndefined/Unknown
Pages (from-to)1761-1771
Number of pages11
JournalEuropean Heart Journal
Volume29
Issue number14
Publication statusPublished - 2008

Cite this